These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10628555

  • 1. Preparation and characterization of technetium complexes with Schiff base and phosphine coordination. 1. Complexes of technetium-99g and -99m with substituted acac2en and trialkyl phosphines (where acac2en = N,N'-ethylenebis[acetylacetone iminato]).
    Marmion ME, Woulfe SR, Neumann WL, Nosco DL, Deutsch E.
    Nucl Med Biol; 1999 Oct; 26(7):755-70. PubMed ID: 10628555
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
    Bolzati C, Benini E, Cazzola E, Jung C, Tisato F, Refosco F, Pietzsch HJ, Spies H, Uccelli L, Duatti A.
    Bioconjug Chem; 2004 Oct; 15(3):628-37. PubMed ID: 15149191
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and characterization of novel N3O3-Schiff base complexes of 99gTc, and in vivo imaging studies with analogous 99mTc complexes.
    Marmion ME, Woulfe SR, Newmann WL, Pilcher G, Nosco DL.
    Nucl Med Biol; 1996 Jul; 23(5):567-84. PubMed ID: 8905821
    [Abstract] [Full Text] [Related]

  • 4. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR.
    Bioconjug Chem; 1997 Jul; 8(2):146-54. PubMed ID: 9095354
    [Abstract] [Full Text] [Related]

  • 5. Mixed-ligand technetium(III) complexes with tetradendate/monodendate NS(3)/isocyanide coordination: a new nonpolar technetium chelate system for the design of neutral and lipophilic complexes stable in vivo.
    Pietzsch HJ, Gupta A, Syhre R, Leibnitz P, Spies H.
    Bioconjug Chem; 2001 Jul; 12(4):538-44. PubMed ID: 11459458
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo characterization of a 99mTc complex with tris(hydroxymethyl)phosphine (THP).
    Berning DE, Katti KV, Singh PR, Higgenbotham C, Reddy VS, Volkert WA.
    Nucl Med Biol; 1996 Jul; 23(5):617-22. PubMed ID: 8905826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of technetium-99m monocationic mixed ligand complexes of phenyl substituted/condensed tetradentate Schiff's bases and trimethylphosphine.
    Goomer NC, Kulkarni PV, Constantinescu A, Antich P, Parkey RW, Corbett JR.
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):679-84. PubMed ID: 1522022
    [Abstract] [Full Text] [Related]

  • 9. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
    Pirmettis IC, Papadopoulos MS, Chiotellis E.
    J Med Chem; 1997 Aug 01; 40(16):2539-46. PubMed ID: 9258360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humans.
    Deutsch E, Vanderheyden JL, Gerundini P, Libson K, Hirth W, Colombo F, Zecca L, Savi A, Fazio F.
    J Nucl Med; 1987 Dec 01; 28(12):1870-80. PubMed ID: 3681444
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
    Boschi A, Uccelli L, Bolzati C, Duatti A, Sabba N, Moretti E, Di Domenico G, Zavattini G, Refosco F, Giganti M.
    J Nucl Med; 2003 May 01; 44(5):806-14. PubMed ID: 12732683
    [Abstract] [Full Text] [Related]

  • 13. Reactivity of rhenium(V) oxo Schiff base complexes with phosphine ligands: rearrangement and reduction reactions.
    Benny PD, Green JL, Engelbrecht HP, Barnes CL, Jurisson SS.
    Inorg Chem; 2005 Apr 04; 44(7):2381-90. PubMed ID: 15792474
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and biodistribution of new 99mTc Oxo and nitrido complexes of unsaturated tetradentate (N2S2)ligands.
    Coulais Y, Cros G, Darbieu MH, Gantet P, Tafani JA, Vende D, Pasqualini R, Guiraud R.
    Nucl Med Biol; 1993 Apr 04; 20(3):263-8. PubMed ID: 8485485
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example.
    Bolzati C, Salvarese N, Carta D, Refosco F, Dolmella A, Pietzsch HJ, Bergmann R, Bandoli G.
    J Biol Inorg Chem; 2011 Jan 04; 16(1):137-55. PubMed ID: 20924624
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m.
    Santimaria M, Blok D, Feitsma RI, Mazzi U, Pauwels EK.
    Nucl Med Biol; 1999 Apr 04; 26(3):251-8. PubMed ID: 10363795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.